Investment Q&A

Q: Looking to add to a diversified portfolio. What would you pick from this list for 10year hold. Looking for best possible return potential. Is there another to consider that’s not part of this list?

Q: Please comment on latest earnings report, balance sheet strength and what your thoughts are on the long term outlook of the company. Thanks!

Q: Hello, I know 5i rate the above very highly but if only one could be purchased at these levels which one would you prefer and why, looking out 3-5 years. Thanks as always Anthony

Q: Does the recent earnings affect your view on SOUN as a longer term hold? Would you be comfortable initiating a position now? Thank-you

Q: In 2025 June, it was confirmed by AGM that PKI is being acquired by SUN:N for US$9.1-bil. SUN:N was offering C$44 or C$19.80 = 0.295 SUN:N units. At of today PKI:T is trading around C$38/-. Do you think that SUN:N will pay C$44 once the transaction related formalities is completed or its better to sell now as the price of C$44 might be lower. Your views appreciated.
Thanks
Piyush

Q: Canadian life insurance companies versus Canadian banks, which would you consider to be the better investment in the current economic context?

Q: With the stock splitting 3 for 2 is now a good time to add to the stock.

Q: Which of these 3 dividend stocks would be your pick for the short and medium term?

fts, cnq and enb.

thanks

Q: WULF Please comment on the company and your thoughts on GOOGL stake/partnership with them.

Q: What do you think about this fund as an income ETF?

Q: Hi Guys
Thanks for all of your great work. I asked a question a couple days ago and accidentally hit “private question”.
You accidentally sent me an answer to someone else’s question.
I’m looking for your top 10 stocks for a TFSA and 10 for non registered account for 5 to 10 yr hold. Moderate risk for a semi retired couple. Also, I’ve held CGXF.TO and was wondering if a 5-10 % allocation in the non registered account is something you feel is fine.
Thanks!

Q: Can you please comment on E's recent Q and it's future prospects. Jason Donville at DKAM sees it as a potential multibagger and I am wondering if this is one of his rare misses or if he is just a little early.

Thanks
Scott

Q: This stock is up 50% in less than a month and is at a 52 week high it also will be making about 270 million going forward this year. They get to keep 90% of that. My simple math has them at a P/E of 6.4 on a forward basis if they don’t overachieve. There drug is getting traction into the hospitals and with the doctors due to its drug profile.

Aurina has another drug in the pipeline going into phase two that looks good and I hope they go after rheumatoid arthritis. To me everything looks good here. This is my fun stock to stop me from becoming too bored and is finally becoming exciting.

What do you folks think is going on here regarding the big move in the stock price and where it could go. Looks like the existing drug revenue tops out an around 600 million annually.

Q: Your thoughts on this stock and whether it is a buy / good bet at this price would be helpful.

Q: How can I invest in AI or companies that are heavily using AI ?

Q: Some of my shorts, (DE, JBHT and DRI) are reacting well in the pre-market. Do you think they are worth holding, as shorts, for a while yet? Can you comment in particular on DE's earnings? Thank-you.

Q: Please name your top 4 companies that are into ART. Intelligence A/I. Brief reason for each pick. Take as many credits as necessary. Thanks. Helen

Q: Please comment on 2nd results.

Thank you

Q: Hello
What is your view on Fulgent Genetics? Thanks for your advice.

Q: Is there anywhere on your website that I can create a portfolio and monitor its performance?

Sheldon